The Critical Link Between Cost, Quality, and Outcomes (CQO) and Unique Device Identification (UDI) White Paper

By AHRMM

In an effort to capture broader insights on UDI adoption from across the health care field, AHRMM, with participation by the FDA, held LUC Data Quality Workshops during four conferences in 2017. During these workshops, conference attendees had the opportunity to voice their opinions on the state of UDI data quality, hurdles to UDI adoption and what recommended practices are necessary for providers and suppliers to effectively capture the UDI and use it in meaningful ways.  

A clear message has emerged from health care stakeholders – the only way to drive greater UDI adoption across the health care field is for the individuals and groups engaged in UDI efforts to collaborate, share their experiences, and learn from each other. In this paper, we leverage these collective insights to present challenges faced by providers and manufacturers today with regards to UDI adoption, and highlight potential solutions that have emerged from the work of the LUC and other health care participants.

 

Related Resources

Case Studies
Leading Practice: Reduction or Elimination of CAUTI - University of Virginia Health System
AHRMM is developing a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Advisories
FDA Releases Proposed Rule on Unique Device System for Medical Devices
The FDA UDI ruling has finally arrived - the proposed rule has published.
Advisories
Medical Device Tax Next Steps
The medical device excise tax is a feature of the Affordable Care Act. It is important to be knowledgeable about the tax and its effects.
Advisories
Final Regulations on Taxable Medical Devices
The final regulations that provide guidance on the excise tax imposed on the sale of certain medical devices, enacted by the Health Care and Educ
Letters/Comments
The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Fo
Advisories
National Provider Call: Hospital Value-Based Purchasing
An overview of Fiscal Year (FY) 2015 Hospital Value-Based Purchasing (VBP) Program.